Home / Metabolic & Weight / Retatrutide
GLP-1 / GIP / Glucagon triple agonist
An investigational triple agonist (GLP-1 / GIP / glucagon) that produced some of the largest body-composition changes ever recorded in a metabolic trial.
Retatrutide and our full lineup are stocked locally and lab-tested with a COA on every batch. Reserve online for pickup, walk in, call, or text. Fresno's premium-grade research peptides, stocked locally. Research use only.
Local pickup at Peptides Express · 6592 N. First Street, Fresno, CA 93710
Products are sold strictly for laboratory and research purposes — not for human consumption.
Retatrutide adds a third receptor — glucagon — to the dual-agonist design, which researchers connect to energy expenditure on top of appetite and glucose signaling. It is the compound generating the most metabolic-research search interest in 2026.
It is still investigational: its Phase 3 program (widely followed under the TRIUMPH name) is a major storyline in the space. That 'investigational' status is exactly why research framing and honest sourcing are non-negotiable here.
Because it is newer and in high demand, it is also a prime target for mislabeled or low-purity product. Third-party COA scrutiny is the whole game.
Every batch is produced to a pharmaceutical-grade standard, verified by in-house and independent third-party testing, and shipped with a batch-specific certificate of analysis — backed by a 100% satisfaction guarantee. Here's exactly what that means, in plain English.
What the term really means — and what it doesn't claim.
Learn → TestingHPLC purity, mass-spec identity, third-party verified.
Learn → DocumentationRead the receipt that proves what's in the vial.
Learn → TransparencyWhat it covers, stated plainly.
Learn →